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Abstract Site-selective dephosphorylation of receptor tyrosine
kinases contributes to receptor regulation. The receptor-like
protein tyrosine phosphatase DEP-1 site-selectively dephosphor-
ylates the PDGF L-receptor. DEP-1 dephosphorylation of
original and chimeric phospho-peptides spanning the preferred
pY1021 and the less preferred pY857 and pY562 sites was
analyzed. Double substitutions of basic residues at 34 and +3 of
pY857 and pY562 peptides improved affinity. Substitutions of
single amino acids indicated preference for an acidic residue at
position 31 and a preference against a basic residue at position
+3. DEP-1 site-selective dephosphorylation of PDGF L-receptor
is thus determined by the primary sequence surrounding phos-
phorylation sites and involves interactions with residues spanning
at least between positions 31 and +3. ß 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Signaling through receptor tyrosine kinases (RTKs) is a
major mechanism for intracellular communication in physio-
logical and pathological settings [1]. Activation and autophos-
phorylation of most RTKs are triggered by ligand-induced
receptor dimerization [2,3]. Phosphorylated tyrosine residues
of RTKs regulate the intrinsic tyrosine kinase activity or act
as docking sites for signaling proteins containing Src homol-
ogy 2 (SH-2) or phosphotyrosine-binding domains. For exam-
ple, in the PDGF L-receptor, phosphorylation of Tyr857 reg-
ulates tyrosine kinase activity whereas phosphorylation of
Tyr1021 creates a binding site for phospholipase C-Q [4].
RTK phosphorylation is also regulated by the action of pro-
tein tyrosine phosphatases (PTPs) [5]. Dephosphorylation of
RTKs by PTPs can lead to general attenuation of receptor
signaling, or modulation of signaling through site-selective
dephosphorylation.
DEP-1 (also designated CD148 or rPTP-R) is a receptor-
like PTP expressed in many cell types including ¢broblasts,
hematopoietic cells, endothelial cells and epithelial cells [6^8].
Structurally, DEP-1 is composed of an extracellular domain
of eight ¢bronectin type III repeats, a transmembrane domain
and an intracellular PTP domain. DEP-1 expression is upreg-
ulated by increasing cell density in endothelial cells, smooth
muscle cells and ¢broblasts [6,8]. DEP-1 negatively regulates
T-cell receptor activation through a mechanism that involves
reduced phosphorylation of phospholipase C-Q and LAT [9^
11]. Loss of DEP-1 expression in thyroid cancer cells and
breast cancer cells, and observations of growth reduction or
di¡erentiation of cancer cells after reconstitution of DEP-1
expression, suggest a possible function of DEP-1 as tumor
suppressor [12^14]. The activity of DEP-1 can be regulated
by ligand-binding; it was recently shown that Matrigel, a
commercial preparation of extracellular matrix components,
contains a DEP-1 agonist [15].
DEP-1 site-selectively dephosphorylates the PDGF L-recep-
tor in vitro as well as in intact cells [16]. This preference for
individual phosphorylation sites was reproduced in peptide
dephosphorylation experiments with PDGF L-receptor-de-
rived phospho-peptides. These observations point to the inter-
esting possibility that the signaling output of the PDGF L-re-
ceptor, and ultimately the biological e¡ects triggered by
receptor activation, is controlled by site-selective PTPs includ-
ing DEP-1. To provide a better understanding of this poorly
understood regulatory phenomenon, we have in this study
investigated the role of the primary sequence, surrounding
preferred and less preferred phosphorylation sites in the
PDGF L-receptor, in determining DEP-1 site-selectivity.
2. Materials and methods
2.1. Expression and puri¢cation of DEP-1 catalytic domain
The segment encoding the catalytic domain (amino acids 997^1337)
of DEP-1 (DEP-1cd) was cloned into the expression vector PET-15b
(Novagen). Protein expression was performed in Escherichia coli
(BL21) grown in 1 l of LB supplemented with 50 Wg/ml ampicillin.
At an optical density of 0.3 at 600 nm, 1 mM isopropyl-L-D-thioga-
lactopyranoside was added. The bacteria were cultured for 3 h at
30‡C, collected by centrifugation and resuspended in 14 ml of bu¡er
A (5 mM imidazole, 0.5 M NaCl and 20 mM Tris pH 7.9) supple-
mented with two protease-inhibitor cocktail tablets Complete1 Mini
EDTA-free (Roche). Lysis was performed by sonication three times
for 30 s at 35% power (Bandelin sonopuls). The lysate was centrifuged
(39 000Ug for 20 min) and the supernatant applied to 4 ml nickel-
charged Sepharose (Novagen). The Sepharose was washed with 100
ml of bu¡er A and DEP-1cd eluted with 24 ml of bu¡er A containing
0.1 M imidazole. The eluted fraction was dialyzed overnight against
bu¡er B (20 mM Tris^HCl pH 8.0, 1 mM Tris(2-carboxyethyl)-phos-
phine hydrochloride (TCEP), 2 mM benzamidine and 2 mM EDTA),
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and applied to a Mono Q 5/5 column (Amersham Pharmacia Bio-
tech). The column was developed with a linear gradient of 0^1 M
NaCl in 20 ml of bu¡er B. DEP-1cd eluted between 100 and 140
mM NaCl. DEP-1cd-containing fractions were pooled and loaded
onto a Superdex 75 16/60 gel ¢ltration column (Amersham Pharmacia
Biotech) equilibrated in 20 mM Tris^HCl pH 8.0 and 1 mM TCEP.
The fractions containing DEP-1cd, which eluted at 63^72 ml, were
pooled and concentrated to approximately 5 mg/ml. Amino acid anal-
ysis was used for determination of the concentration of puri¢ed DEP-
1cd. The protein was stored at 320‡C.
2.2. Peptide synthesis and in vitro phosphatase assay
All peptides were synthesized following the Fmoc strategy with
Fmoc-amide resin, resulting in carboxy-terminally amidated peptides.
For phosphotyrosine, Fmoc-Tyr(PO3H2)-OH (Novabiochem) was
used. Peptides were puri¢ed by reversed phase high-performance liq-
uid chromatography using a C18 column, and matrix-assisted laser
desorption ionization^time of £ight^mass spectrometry analysis con-
¢rmed the correct, expected molecular weights. Concentrations of
peptides were determined by measuring di¡erences in absorbance at
282 nM of phosphorylated and fully dephosphorylated peptides. The
dephosphorylation of phosphotyrosine-containing peptides was mea-
sured spectrophotometrically by continuously monitoring the increase
in absorbance at 282 nm [17]. Initial rates were determined from the
graphs obtained. All measurements were performed at 30‡C in 500 Wl
of a bu¡er containing 20 mM Tris^HCl pH 7.5, 0.15 M NaCl, 1 mM
EDTA and 2 mM 1,4-dithiothreitol. The peptide concentration
ranged from 50 to 5000 WM, which is within the linear range of ab-
sorbance. Kinetic parameters were obtained from Lineweaver^Burk
plots using the program Enzyme Kinetics (Trinity Software), which
uses a concentration-dependent weighting scheme. In some experi-
ments dephosphorylation rates were measured by determining the
amount of phospho-peptide (starting concentration of 50 WM) remain-
ing after 25 s of incubation with 50 nM DEP-1cd.
3. Results
3.1. Puri¢cation of DEP-1 catalytic domain
The catalytic domain of DEP-1 (DEP-1cd) comprising ami-
no acids 997^1337 was expressed as an amino-terminal histi-
dine-tagged protein in E. coli cells. The recombinant protein
was puri¢ed from the soluble fraction of the cell lysate by
metal a⁄nity chromatography followed by ion-exchange
chromatography and gel ¢ltration. Fractions from the di¡er-
ent puri¢cation stages were analyzed by SDS^PAGE and
Coomassie blue staining (Fig. 1). The purity of ¢nal DEP-
1cd was estimated to be s 90% as determined from SDS^
PAGE; the yield from 1 l of culture was approximately 5 mg.
3.2. Di¡erence in DEP-1cd dephosphorylation e⁄ciency of the
pY857 and pY1021 peptides is caused by a di¡erence in
a⁄nity
It has previously been shown that DEP-1 site-selectively
dephosphorylates the PDGF L-receptor [16]. One of the
most preferred sites was pY1021 whereas pY857 was found
to be a poorer substrate. To further characterize pY1021 and
pY857 as substrates for DEP-1, phosphotyrosine decapeptides
containing these sites were synthesized (Table 1). The dephos-
phorylation was assayed by measuring the increase in absor-
bance at 282 nm and kinetic parameters were determined from
Lineweaver^Burk plots (Fig. 2A). Both phospho-peptides
pY1021 and pY857 exhibit similar kcat values of 770 s31
and 1100 s31, respectively. However, the Km for pY1021 is
10-fold lower than that for pY857 (480 WM and 4800 WM,
respectively). This analysis thus reveals that the previously
observed preference of DEP-1 for the pY1021 peptide, as
compared to the pY857 peptide, is caused by a much higher
a⁄nity for pY1021 rather than a higher kcat value.
3.3. DEP-1cd substrate selectivity is reversed for chimeric
pY857/1021 peptides containing substitutions in positions
34 and +3
Besides pY857, the phosphorylation site pY562 in the
PDGF L-receptor has been shown to be a poor substrate
for DEP-1 [16]. Common to these two sites are basic amino
acid residues in positions 34 and +3 relative to the phospho-
tyrosine (Table 1). In order to investigate if these amino acid
residues are responsible for the negative selection by DEP-1,
two peptide chimeras were synthesized. In one peptide
(pY857GP), the amino acid residues in positions 34 and +3
were replaced with the corresponding residues from the
pY1021 peptide. Conversely, the equivalent positions in the
pY1021 peptide were substituted with residues from the
pY857 peptide (pY1021RK; Table 1). The kcat values of the
chimeric peptides remained unchanged compared to the orig-
inal peptides. However the Km of pY857GP was decreased
about four-fold while a four-fold increase in Km for the
pY1021RK peptide was observed (Fig. 2B). These ¢ndings
suggest that the arginine and/or lysine residues in positions
34 and +3 contribute to the poor dephosphorylation of
pY857 by DEP-1cd.
3.4. The pY562 peptide is improved as a DEP-1cd substrate by
substitutions with amino acids from pY1021 peptide in
positions 34 and +3
To investigate if the improvement of pY857 as a DEP-1cd
substrate could be reproduced for the pY562 phosphorylation
site, a pY562 phospho-peptide with substitutions from
pY1021 peptide in positions 34 and +3 was synthesized (Ta-
ble 1). Since the corresponding pY562 decapeptide contains
an amino-terminal glutamine residue, an additional amino
acid residue was added to avoid the formation of a pyroglu-
tamate. The high background absorbance of pY562 and
pY562GP, due to the presence of two tryptophan residues,
prevented analysis over a broad range of substrate concentra-
tions and subsequent calculations of kinetic parameters. In-
stead, dephosphorylation was performed at a ¢xed substrate
concentration of 50 WM, and the amount of phospho-peptide
left after 25 s was determined. The fraction of phospho-pep-
Fig. 1. SDS^PAGE analysis of puri¢cation of DEP-1 catalytic do-
main. The catalytic domain of DEP-1 (DEP-1cd) was expressed in
E. coli. Cell lysate (lane 1) was applied to a nickel-charged Sepha-
rose column and the eluted fraction (lane 2) was further puri¢ed by
ion-exchange chromatography, followed by size exclusion chroma-
tography (lane 3). Fractions were analyzed by SDS^PAGE and
Coomassie blue staining.
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tide pY562 left after incubation of DEP-1cd was 71% whereas
the fraction remaining of phospho-peptide pY562GP was only
47% (Fig. 3). Similarly, pY857, which was included in this
assay as a reference peptide, was dephosphorylated less e⁄-
ciently than pY857GP, in agreement with the results in Fig. 2.
This indicates that the presence of basic amino acid residues
in positions 34 and +3 also contributes to the low dephos-
phorylation of the pY562 peptide by DEP-1.
3.5. The introduction of alanine residues in positions 34 and +3
in pY857 peptide improves the peptide as a DEP-1cd
substrate
In order to determine if the observed improvement in de-
phosphorylation e⁄ciency of pY857GP and pY562GP is due
to the removal of the positively charged arginine and lysine
residues, or to the speci¢c introduction of glycine and proline
residues, a pY857 peptide containing alanine residues in posi-
tions 34 and +3 (pY857AA; Table 1) was synthesized and
analyzed as DEP-1cd substrate. While all peptides exhibited
similar kcat values, the Km of pY857AA was decreased about
three-fold compared to pY857. As shown in Fig. 4, the Km of
pY857AA was almost as low as that of pY857GP (1300 WM
and 1200 WM, respectively). Hence, the increase in a⁄nity of
pY857GP, as compared to the original pY857 peptide, for
DEP-1cd is most likely due to the removal of positively
charged amino acid residues rather than the speci¢c introduc-
tion of residues from the pY1021 peptide in positions 34 and
+3.
3.6. The lysine residue in position +3 contributes most to the
low a⁄nity of pY857
To further examine to what extent each individual amino
acid surrounding the phosphotyrosine in pY1021 contributes
to DEP-1cd selectivity, chimeric peptides were synthesized in
which single amino acid residues in pY857 were substituted
with residues in pY1021 at position 34 throughout position
+3 (pY857G, pY857N, pY857D, pY857I, pY857P; Table 1).
Kinetic parameters of the DEP-1cd-catalyzed dephosphoryla-
tion of the peptides were determined (Table 2) except for
pY857I, which exhibited poor solubility. A slight decrease in
Km of pY857G and pY857N could be observed whereas the
Km of pY857D was decreased two-fold. The greatest increase
in a⁄nity was shown for pY857P with a Km (1600 WM) nearly
as low as for pY857GP (1200 WM). No dramatic changes of
the kcat values were observed.
Furthermore, single amino acid residues at positions 34
and +3 in pY1021 were substituted with residues in pY857
(pY1021R and pY1021K; Table 1). Only pY1021R was sub-
jected to phosphatase assays since pY1021K displayed low
solubility. The Km of pY1021R was only slightly higher
than for the original pY1021 peptide, indicating that the
four-fold lowered a⁄nity of pY1021RK is mainly caused by
the introduction of the lysine in position +3.
From these ¢ndings, we conclude that the lysine residue in
position +3 in pY857 is a major negative determinant for the
dephosphorylation by DEP-1cd.
3.7. Introduction of a lysine residue in position +2 of pY1021
reduces a⁄nity for DEP-1cd
Basic amino acid residues at all positions between 34 and
+4 relative to the phospho-tyrosine have previously been
shown to be detrimental for peptide dephosphorylation by
Table 1
Amino acid sequence of PDGF L-receptor-derived tyrosine-phos-
phorylated peptides
Peptide Sequence
pY857 MRDSNpYISKG
pY1021 EGDNDpYIIPL
pY562 WQKKPRpYEIRW
pY857GP MGDSNpYISPG
pY857AA MADSNpYISAG
pY857G MGDSNpYISKG
pY857N MRDNNpYISKG
pY857D MRDSDpYISKG
pY857I MRDSNpYIIKG
pY857P MRDSNpYISPG
pY1021RK ERDNDpYIIKL
pY1021R ERDNDpYIIPL
pY1021K EGDNDpYIIKL
pY1021K+2 EGDNDpYIKPL
pY1021K+1 EGDNDpYKIPL
pY562GP WQGKPRpYEIPW
Bold letters indicate substituted amino acids.
Fig. 2. DEP-1cd-catalyzed dephosphorylation of phospho-peptides
pY1021, pY857, pY857GP and pY1021RK. DEP-1cd at a concen-
tration of 50 nM was incubated with 50^4550 WM of the phospho-
peptides and dephosphorylation measured spectrophotometrically.
Lineweaver^Burk plots and kinetic parameters for DEP-1cd dephos-
phorylation of peptides pY857 and pY1021 (A) and peptides
pY857GP and pY1021RK (B) are shown. The results are represen-
tative for ¢ve experiments.
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PTP1B [18]. To investigate if basic residues at other carboxy-
terminal positions than +3 also act as negative determinants
for DEP-1cd, lysines were introduced at positions +1 and +2
in pY1021 (pY1021K+1 and pY1021K+2; Table 1). The in-
troduction of a lysine in position +1 had only a minor e¡ect
on a⁄nity, increasing Km less than two-fold. Lysine in posi-
tion +2 resulted in a three-fold increase in Km. Hence, in
addition to position +3, lysine in position +2 is poorly toler-
ated by DEP-1cd whereas a basic residue in position +1 is
better accepted.
4. Discussion
In summary, a lysine at position +3 was identi¢ed as a
negative determinant of DEP-1 preference and an aspartic
acid residue at position 31 was found to be a positive deter-
minant. More generally, our study shows that the preference
displayed by DEP-1 is dictated by sequences extending at least
as far as position +3.
Basic residues in the vicinity of the phospho-tyrosine have
also been found to act as negative determinants in the speci-
¢city of other PTPs, e.g. PTP-1B and T-cell phosphatase
[18,19]. The negative e¡ect of a basic residue carboxy-terminal
of the phospho-tyrosine appears to be position-dependent
since smaller e¡ects were observed when a lysine was intro-
duced at position +2, and the e¡ects were still smaller when
the lysine was at the +1 position. This is thus in contrast to
observations for PTP-1B speci¢city where selection against
basic residues was observed at all positions between +1 and
+4 [18]. The preference for negatively charged residues at
position 31 has also been described for PTP-1B [20].
Structural studies of peptide/PTP complexes have provided
the most detailed information concerning molecular interac-
tions determining PTP speci¢city. Such complexes are avail-
able for PTP-1B and the peptides DADEpYL, ELEF-
pYMDE, and ETDpYpYRKGGKGLL, as well as for SHP-
1 and the SIRPK peptides EDTLTpYADLD and PSFSE-
pYASVQ [21^24]. The regions of the PTPs involved in peptide
interactions cluster around the K1/L1-loop and the K5-loop-K6
region, and in the case of the SHP-1/EDTLTpYADLD com-
plex, the L5-loop-L6, as well (reviewed in [25]). The PTP-1B
complexes display speci¢c side chain/side chain interactions
with residues at positions 34 to 31 and +1. Substrate resi-
dues in the +2 and +3 positions have been placed at poorly
de¢ned locations distant from the protein. Our study points to
the importance of residues in position +3, which suggests that
speci¢c interactions occur at positions not yet identi¢ed in
these peptide/PTP complexes. This idea is supported by a
study of PTP-1B speci¢city, where signi¢cant di¡erences in
kcat/Km values were observed between peptides varying exclu-
sively in position +3 [18].
The complexes between SHP-1 and the two SIRPK peptides
are reported to have a very di¡erent docking of the peptide as
compared to the PTP1B/peptide complexes; a +3-binding
pocket was identi¢ed, composed of Ser498, Ile281 and
Lys259 [24]. At the corresponding positions in DEP-1 are
proline, valine and serine residues, respectively, residues which
would not be expected to speci¢cally disfavor binding of a
positively charged side chain. The available structural data,
therefore, do not indicate which regions in DEP-1 are respon-
sible for the preference against basic residues at position +3.
The issue of preference for various PDGF L-receptor-de-
rived phospho-peptides has been investigated with the IF2
isoform of LMW-PTP, another enzyme with PTP activity
that has been implicated in control of PDGF L-receptor sig-
naling [26]. This enzyme, which is a member of the structur-
ally distinct low-molecular weight PTP family, displayed a
reverse preference compared with DEP-1, i.e. the a⁄nity of
Fig. 3. Dephosphorylation of phospho-peptides pY562, pY562GP,
pY857 and pY857GP by DEP-1cd. 50 nM of DEP-1cd was incu-
bated with the phospho-peptides at a starting concentration of 50
WM and the fraction of phospho-peptide left after 25 s was deter-
mined. Data are means of three separate experiments. Error bars in-
dicate standard deviation.
Table 2
Kinetic parameters of pY857, pY1021 and chimeric pY857/1021
peptides
Peptide Km (WM) kcat (s31)
pY857 4200 810
pY1021 480 710
pY857GP 1200 940
pY1021RK 2300 560
pY857G 3400 830
pY857N 3600 820
pY857D 2200 800
pY857P 1600 870
pY1021R 540 720
pY1021K+1 760 740
pY1021K+2 1400 840
The values are representative for two experiments.
Fig. 4. DEP-1cd-catalyzed dephosphorylation of phospho-peptides
pY857, pY857AA and pY857GP. DEP-1cd at a concentration of 25
nM was incubated with the phospho-peptides pY857, pY857AA and
pY857GP at 100^5000 WM and dephosphorylation measured spec-
trophotometrically. Results are shown as Lineweaver^Burk plots
and kinetic parameters indicated. The results are representative for
two experiments.
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the IF2 isoform of LMW-PTP was higher for the pY857
phospho-peptide than for the pY1021 phospho-peptide.
Thus, the preference among PDGF L-receptor-derived phos-
pho-peptides that DEP-1 displays is not shared by all enzymes
involved in PDGF L-receptor dephosphorylation.
Our ¢ndings are consistent with a role for regulated site-
selective dephosphorylation in ¢ne-tuning of the signaling of
PDGF L-receptor, and possibly other signaling proteins con-
taining multiple tyrosine phosphorylation sites. The biological
response to PDGF receptor activation is determined by the
strength and duration of signaling emanating from SH-2 do-
main-containing enzymes recruited to the receptor. It is thus
an interesting possibility that the regulated action of di¡erent
site-selective PTPs represents a mechanism for altering the
biological responses following ligand stimulation of PDGF
receptors or other tyrosine kinase receptors. The availability
of cell lines derived from mice with genetically inactivated
PTPs acting on the PDGF receptor should make it possible
to test this hypothesis.
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